SUN PHARMACEUTICAL INDUSTRIES LTD. - Open Offer to the shareholders of Zenotech Laboratories
Download 
|
< Back |
| 11 Apr 2014 | |
| Citigroup Global Markets India Private Limited ("Manager to the Offer") has submitted to BSE a copy of public announcement regarding Open Offer to the equity shareholders of Zenotech Laboratories Limited (Zenotech / Target Company) by Sun Pharmaceutical Industries Limited ("Sun Pharma" / "Acquirer").<br/><br/>Offer Details<br/><br/>Size: Up to 9,693,332 fully paid up equity shares of face value of INR 10 (Indian rupees ten only) each of the Target Company (Offer Shares), constituting 28.1 % of the fully diluted voting share capital of the Target Company as of the 10th (tenth) working day from the date of closure of the tendering period, at a price of INR 19 (Indian rupees nineteen only) per Offer Share (Offer Price) aggregating to INR 184,173,308 (Indian rupees one hundred and eighty four million one hundred and seventy three thousand three hundred and eight only), subject to the terms and conditions mentioned in this Public Announcement, the detailed public statement (DPS) and the letter of offer that may be issued in accordance with the SEBI (SAST) Regulations.<br/><br/>Price / Consideration: INR 19 (Indian rupees nineteen only) per Offer Share determined by the Acquirer and the Manager taking into account the provisions of Regulation 8(3) and Regulation 8(4) of the SEBI (SAST) Regulations and the valuation report dated April 10, 2014 issued by M/s Bansi S. Mehta and Co., Chartered Accountants. The equity shares of the Target Company are infrequently traded as per Regulation 2(1)(j) of the SEBI (SAST) Regulations. | |
| View all announcements for SUN PHARMACEUTICAL INDUSTRIES LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback